Jean-Marie Eveillard - First Eagle Investment Management
Holding/activity history for Protalix Biotherapeutics Inc (PLX)
← All PLX superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2014 Q1 | 0 | 0.00 | Sell 100.00% | 0.01 | $38.40–53.00 · VW $45.59i | SEC | |
| 2013 Q4 | 70,000 | 0.01 | Add 40.00% | <0.01 | $37.00–46.70 · VW $41.26i | $2,723,000 | SEC |
| 2013 Q3 | 50,000 | 0.01 | $45.30 | $2,265,000 | SEC | ||
| 2013 Q2 | 50,000 | 0.01 | $49.10 | $2,455,000 | SEC | ||
| 2013 Q1 | 50,000 | 0.01 | Reduce 23.08% | <0.01 | $50.10–67.30 · VW $56.86i | $2,745,000 | SEC |
| 2012 Q4 | 65,000 | 0.02 | $51.90 | $3,374,000 | SEC | ||
| 2012 Q3 | 65,000 | 0.02 | $51.80 | $3,367,000 | SEC | ||
| 2012 Q2 | 65,000 | 0.02 | Buy | 0.02 | $53.10–77.00 · VW $65.57i | $3,725,000 | SEC |